“Canada has world‑class talent and a strong life sciences innovation base,” said Parimal Nathwani, Managing Partner, Life Sciences Venture Fund, BDC Capital. “But with a significant early‑stage funding gap, combined with long development cycles and demanding scientific validation, the needs are pressing. By supporting early‑stage companies in therapeutics and medical devices, we aim to turn Canadian research and intellectual property into globally competitive businesses that improve human health, create high‑quality jobs, generate economic impact and strengthen Canada’s innovation ecosystem.”